These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 32006562)

  • 1. Temporal development of neurochemical and cognitive impairments following reserpine administration in rats.
    Pereira AG; Poli A; Matheus FC; de Bortoli da Silva L; Fadanni GP; Izídio GS; Latini A; Prediger RD
    Behav Brain Res; 2020 Apr; 383():112517. PubMed ID: 32006562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the mesocorticolimbic pathway after low dose reserpine-treatment in Wistar and Spontaneously Hypertensive Rats (SHR): Implications for cognitive deficits in a progressive animal model for Parkinson's disease.
    Leão AHFF; Meurer YSR; Freitas TA; Medeiros AM; Abílio VC; Izídio GS; Conceição IM; Ribeiro AM; Silva RH
    Behav Brain Res; 2021 Jul; 410():113349. PubMed ID: 33971246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive and anxiety-like impairments accompanied by serotonergic ultrastructural and immunohistochemical alterations in early stages of parkinsonism.
    Leal PC; Bispo JMM; Lins LCRF; Souza MF; Gois AM; Moore C; Marchioro M; Ribeiro AM; Silva RH; Meshul CK; Santos JR
    Brain Res Bull; 2019 Mar; 146():213-223. PubMed ID: 30641120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term atrazine exposure causes behavioral deficits and disrupts monoaminergic systems in male C57BL/6 mice.
    Lin Z; Dodd CA; Filipov NM
    Neurotoxicol Teratol; 2013; 39():26-35. PubMed ID: 23770127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the second-generation "bath salt" cathinone alpha-pyrrolidinopropiophenone (α-PPP) on behavior and monoamine neurochemistry in male mice.
    Ray A; Chitre NM; Daphney CM; Blough BE; Canal CE; Murnane KS
    Psychopharmacology (Berl); 2019 Mar; 236(3):1107-1117. PubMed ID: 30276421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated treatment with a low dose of reserpine as a progressive model of Parkinson's dementia.
    Ikram H; Haleem DJ
    Pak J Pharm Sci; 2019 Mar; 32(2):555-562. PubMed ID: 31081766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential impairment of short working and spatial memories in a rat model of progressive Parkinson's disease onset: A focus on the prodromal stage.
    Draoui A; El Hiba O; Abdelaati EK; Abbaoui A; El Fari R; Aitihya M; Gamrani H
    Brain Res Bull; 2019 Aug; 150():307-316. PubMed ID: 31228545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hippocampal and prefrontal dopamine D1/5 receptor involvement in the memory-enhancing effect of reboxetine.
    De Bundel D; Femenía T; DuPont CM; Konradsson-Geuken Å; Feltmann K; Schilström B; Lindskog M
    Int J Neuropsychopharmacol; 2013 Oct; 16(9):2041-51. PubMed ID: 23672849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral and neurochemical effects induced by reserpine in mice.
    de Freitas CM; Busanello A; Schaffer LF; Peroza LR; Krum BN; Leal CQ; Ceretta AP; da Rocha JB; Fachinetto R
    Psychopharmacology (Berl); 2016 Feb; 233(3):457-67. PubMed ID: 26514557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice.
    Koda K; Ago Y; Cong Y; Kita Y; Takuma K; Matsuda T
    J Neurochem; 2010 Jul; 114(1):259-70. PubMed ID: 20403082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early changes in neuropeptide mRNA expression in the striatum following reserpine treatment.
    Harrison MB; Kumar S; Hubbard CA; Trugman JM
    Exp Neurol; 2001 Feb; 167(2):321-8. PubMed ID: 11161620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation and blockade of serotonin
    Liu KC; Li JY; Xie W; Li LB; Zhang J; Du CX; Zhang YM; Tan HH; Wang HS; Zhang L
    Brain Res; 2016 Nov; 1650():184-195. PubMed ID: 27616337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anxiety-like behavior induced by 6-OHDA animal model of Parkinson's disease may be related to a dysregulation of neurotransmitter systems in brain areas related to anxiety.
    Vieira JCF; Bassani TB; Santiago RM; de O Guaita G; Zanoveli JM; da Cunha C; Vital MABF
    Behav Brain Res; 2019 Oct; 371():111981. PubMed ID: 31141725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex differences in the progressive model of parkinsonism induced by reserpine in rats.
    Bispo JMM; Melo JEC; Gois AM; Leal PC; Lins LCRF; Souza MF; Medeiros KAAL; Ribeiro AM; Silva RH; Marchioro M; Santos JR
    Behav Brain Res; 2019 May; 363():23-29. PubMed ID: 30690108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of early life permethrin exposure on spatial working memory and on monoamine levels in different brain areas of pre-senescent rats.
    Nasuti C; Carloni M; Fedeli D; Gabbianelli R; Di Stefano A; Serafina CL; Silva I; Domingues V; Ciccocioppo R
    Toxicology; 2013 Jan; 303():162-8. PubMed ID: 23174539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carvacrol prevents impairments in motor and neurochemical parameters in a model of progressive parkinsonism induced by reserpine.
    Lins LCRF; Souza MF; Bispo JMM; Gois AM; Melo TCS; Andrade RAS; Quintans-Junior LJ; Ribeiro AM; Silva RH; Santos JR; Marchioro M
    Brain Res Bull; 2018 May; 139():9-15. PubMed ID: 29378222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of intranasal exposure of MPTP in multiple doses on liver functions and transition from non-motor to motor symptoms in a rat PD model.
    Datta I; Mekha SR; Kaushal A; Ganapathy K; Razdan R
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Feb; 393(2):147-165. PubMed ID: 31468077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Withdrawal from repeated administration of a low dose of reserpine induced opposing adaptive changes in the noradrenaline and serotonin system function: a behavioral and neurochemical ex vivo and in vivo studies in the rat.
    Antkiewicz-Michaluk L; Wąsik A; Możdżeń E; Romańska I; Michaluk J
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Mar; 57():146-54. PubMed ID: 25445479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microdialysis study of the effects of the antiparkinsonian drug budipine on L-DOPA-induced release of dopamine and 5-hydroxytryptamine by rat substantia nigra and corpus striatum.
    Biggs CS; Starr MS
    Synapse; 1999 Oct; 34(1):36-46. PubMed ID: 10459170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of striatum-mediated behavior and neurochemistry in the DJ-1 knock-out rat model of Parkinson's disease.
    Giangrasso DM; Furlong TM; Keefe KA
    Neurobiol Dis; 2020 Feb; 134():104673. PubMed ID: 31734455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.